Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice
Open Access
- 16 March 2006
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 13 (14) , 1118-1126
- https://doi.org/10.1038/sj.gt.3302749
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer VectorJournal of Virology, 2005
- Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5Journal of Virology, 2004
- Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunityJournal of Virology, 2003
- Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vectorGene Therapy, 2003
- Impact of Preimmunization on Adenoviral Vector Expression and Toxicity in a Subcutaneous Mouse Cancer ModelMolecular Therapy, 2002
- Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of DiseaseJournal of Virology, 2002
- Replication-Defective Vector Based on a Chimpanzee AdenovirusJournal of Virology, 2001
- Maturation and Lineage‐Specific Expression of the Coxsackie and Adenovirus Receptor in Hematopoietic CellsThe International Journal of Cell Cloning, 2000
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmidGene Therapy, 1999